There’s hope for bowel control issues
Bowel control problems are common, but they are not a normal part of aging. Bowel control problems affect more than 21.4 million adults in the U.S. 1,2,3 If you’re one of them, you know how much chronic FI can interrupt your life. You may have tried changing your diet, physical therapy, or medications. But the results just aren’t what you hoped.
The InterStim™ system targets the nerves that may cause bowel leakage.5,6. It can help you regain control of your bowel symptoms and return to the activities you love.4
Target the problem
The Medtronic InterStim™ system targets the nerves that control your bowel.5,6 This may improve how your bowel communicates with your brain and restore* normal bowel function.4,5,6
Discover proven relief
The Medtronic InterStim™ system can help, even if other treatments have failed. 89% of people using the InterStim system experience long-term symptom relief.4
Try it out before deciding
Find out if the InterStim™ system will work for you through an in-office trial. This allows you to test-drive the device and see how it works before making a long-term commitment.‡
* Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will provide you with the information regarding how to operate the test device, and inform you of other precautions related to the evaluation and activity restrictions.
† Restored bowel function is defined as 50% or more reduction in chronic fecal incontinence episodes.
Your Team of Experts
Firstname Lastname, MD
Small bio goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Firstname Lastname, MD
Small bio goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Firstname Lastname, MD
Small bio goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Locations
Find the right place to start
Office Name
123 Address
City, ST 00000
Office Name
123 Address
City, ST 00000
Treatment
How does it work?
Communication is what helps your bowel work properly.
As the rectum fills with waste, nerves tell your brain “it’s time to go.” Research suggests that poor bowel-brain communication may cause chronic bowel leakage.5,6 In other words, your bowel may get the message too late…or not at all.
The InterStim™ system stimulates the sacral nerves. This can improve how the bowel communicates with the brain and may ultimately improve bowel function.5,6
Ready for a solution for bowel incontinence?
Request an appointment today!
"*" indicates required fields
Get back to less worry and more living
Important Safety Information
Medtronic bladder control therapy delivered by the InterStim™ system treats urinary retention (inability to completely empty the bladder) and the symptoms of overactive bladder, including urinary urge incontinence (leakage) and significant symptoms of urgency-frequency. It should be used after you have tried other treatments such as medications and behavioral therapy and they have not worked, or you could not tolerate them. This therapy is not intended for patients with a urinary blockage.
Safety and effectiveness have not been established for pregnancy and delivery; patients under the age of 16; or for patients with neurological disease origins.
Medtronic bowel control therapy delivered by the InterStim™ system treats chronic fecal incontinence (an accident or leaking involving stool). It should be used after you have tried other treatments such as medications and dietary modifications and they have not worked, or if you are not a candidate for them.
Safety and effectiveness have not been established for pregnancy and delivery; patients under the age of 18; or for patients with progressive, systemic neurological diseases.
Medtronic bladder control therapy and Medtronic bowel control therapy: You must demonstrate an appropriate response to the evaluation to be a candidate. You cannot have diathermy (deep heat treatment from electromagnetic energy) if you have an InterStim™ device.
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, interactions with certain other devices or diagnostic equipment such as MRI, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling).
This therapy is not for everyone. This treatment is prescribed by your doctor. Please talk to your doctor to decide whether this therapy is right for you. Your doctor should discuss all potential benefits and risks with you. Although many patients may benefit from the use of this treatment, results may vary. For further information, please call Medtronic at 800-328-0810 and/or consult the Medtronic website at medtronic.com.
United States Rx only. Rev 0517.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information. Not all patients will experience the same results. In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, interactions with certain other devices or diagnostic equipment such as MRI, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling).
CITATIONS
- Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterol. 2009;137(2):512-517.
- Ditah I, Devaki P, Luma HN et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol. 2014;12:636-643.
- US Census Bureau 2020. US adult and under-age-18 populations: 2020 census. https://www.census.gov/library/visualizations/interactive/adult-and-under-the-age-of-18-populations-2020-census.html. Accessed June 20, 2022.
- Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234-245.
- Lundby L, Moeller A, Buntzen S, et al. Relief of fecal incontinence by sacral nerve stimulation linked to focal brain activation. Dis Colon Rectum. 2011;54(3):318-323.
- Janssen PTJ, Komen N, Melenhorst J, et al. Sacral neuromodulation for fecal incontinence: a review of the central mechanisms of action. J Clin Gastroenterol. 2017;51(8):669-676.